Background: Chronic atrophic gastritis (CAG) alone is a precancerous condition for gastric cancer. Achlorhydria plays an important role in the formation of a class I carcinogen, acetaldehyde. L-cysteine has been claimed to bind acetaldehyde covalently. Symptoms are present in 55% of CAG patients, of whom 70% have upper gastrointestinal complaints. The aim of this study was to investigate the properties of L-cysteine in the modification of symptom patterns in CAG patients. Methods: Consecutive patients with histological diagnosis of CAG (OLGA ≥1 with gastric corpus involvement) were evaluated with serological determination of gastric function, clinical assessment of symptoms using the visual analog score (VAS) and the global symptomatic score (GSS), and considered for therapy with L-cysteine, 300 mg daily. Data regarding symptoms were collected at enrollment and after 3, 6, 12, 18, and 24 months, with an ultimate follow-up of 2 years. Results: A total of 330 patients with CAG were divided in group 1 (77 patients treated with L-cysteine) and group 2 (50 patients who received no specific treatment – control group). A statistically significant improvement in the VAS score (7.8 at baseline vs. 4.5 after 24 months; p < 0.01) was observed in patients treated with L-cysteine, while no significant changes in symptom pattern/intensity were recorded in the 2-year follow-up of untreated patients with CAG. Conclusions: Long-term treatment with L-cysteine provides symptom improvement in CAG patients and might be proposed as maintenance therapy in such patients.

1.
Sipponen
P
,
Kekki
M
,
Haapakoski
J
,
Ihamäki
T
,
Siurala
M
.
Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data
.
Int J Cancer
.
1985
;
35
(
2
):
173
7
.
2.
de Vries
AC
,
van Grieken
NC
,
Looman
CW
,
Casparie
MK
,
de Vries
E
,
Meijer
GA
,
.
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in The Netherlands
.
Gastroenterology
.
2008
;
134
(
4
):
945
52
.
3.
Agréus
L
,
Kuipers
EJ
,
Kupcinskas
L
,
Malfertheiner
P
,
Di Mario
F
,
Leja
M
,
.
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers
.
Scand J Gastroenterol
.
2012 Feb
;
47
(
2
):
136
47
.
4.
Dixon
MF
,
Genta
RM
,
Yardley
JH
,
Correa
P
,
Batts
KP
,
Dahms
BB
.
Classification and grading of gastritis: the updated sydney system
.
Am J Surg Pathol
.
1996
;
20
(
10
):
1161
81
.
5.
Rugge
M
,
Meggio
A
,
Pennelli
G
,
Piscioli
F
,
Giacomelli
L
,
De Pretis
G
,
.
Gastritis staging in clinical practice: the OLGA staging system
.
Gut
.
2007
;
56
(
5
):
631
6
.
6.
Capelle
LG
,
de Vries
AC
,
Haringsma
J
,
Ter Borg
F
,
de Vries
RA
,
Bruno
MJ
,
.
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis
.
Gastrointest Endosc
.
2010
;
71
(
7
):
1150
8
.
7.
Sugano
K
,
Tack
J
,
Kuipers
EJ
,
Graham
DY
,
El-Omar
EM
,
Miura
S
,
.
Kyoto global consensus report on helicobacter pylori gastritis
.
Gut
.
2015 Sep 1
;
64
(
9
):
1353
67
.
8.
Malfertheiner
P
,
Megraud
F
,
O’Morain
CA
,
Gisbert
JP
,
Kuipers
EJ
,
Axon
AT
,
.
Management of helicobacter pylori infection-the Maastricht V/Florence consensus report
.
Gut
.
2017 Oct 1
;
66
(
1
):
6
30
.
9.
Samloff
IM
,
Varis
K
,
Ihamaki
T
,
Siurala
M
,
Rotter
JI
.
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology: a study in relatives of patients with pernicious anemia
.
Gastroenterology
.
1982 Jul
;
83
(
1 pt 2
):
204
9
.
10.
Germaná
B
,
Di Mario
F
,
Cavallaro
LG
,
Moussa
AM
,
Lecis
P
,
Liatoupolou
S
,
.
Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care
.
Dig Liver Dis
.
2005 Jul
;
37
(
7
):
501
8
.
11.
Lee
JY
,
Kim
N
,
Lee
HS
,
Oh
JC
,
Kwon
YH
,
Choi
YJ
,
.
Correlations among endoscopic, histologic and serologic diagnoses for the assessment of atrophic gastritis
.
J Cancer Prev
.
2014 Mar 30
;
19
(
1
):
47
55
.
12.
Venerito
M
,
Radünz
M
,
Reschke
K
,
Reinhold
D
,
Frauenschläger
K
,
Jechorek
D
,
.
Autoimmune gastritis in autoimmune thyroid disease
.
Aliment Pharmacol Ther
.
2015 Apr 1
;
41
(
7
):
686
93
.
13.
Sipponen
P
,
Ranta
P
,
Helske
T
,
Kääriäinen
I
,
Mäki
T
,
Linnala
A
,
.
Atrophic gastritis serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study
.
Scand J Gastroenterol
.
2002
;
37
(
7
):
785
91
.
14.
Väänänen
H
,
Vauhkonen
M
,
Helske
T
,
Kääriäinen
I
,
Rasmussen
M
,
Tunturi-Hihnala
H
,
.
Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study
.
Eur J Gastroenterol Hepatol
.
2003 Aug
;
15
(
8
):
885
91
.
15.
Barchi
A
,
Miraglia
C
,
Violi
A
,
Cambiè
G
,
Nouvenne
A
,
Capasso
M
,
.
A non-invasive method for the diagnosis of upper GI diseases
.
Acta Biomed
.
2018
;
89
(
8-S
):
40
3
.
16.
Niemelä
S
,
Karttunen
T
,
Kerola
T
.
Helicobacter pylori-associated gastritis. Evolution of histologic changes over 10 years
.
Scand J Gastroenterol
.
1995
;
30
(
6
):
542
9
.
17.
Valle
J
,
Kekki
M
,
Sipponen
P
,
Ihamäki
T
,
Siurala
M
.
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study
.
Scand J Gastroenterol
.
1996
;
31
(
6
):
546
50
.
18.
Shah
SC
,
Piazuelo
MB
,
Kuipers
EJ
,
Li
D
.
AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review
.
Gastroenterology
.
2021 Oct 1
;
161
(
4
):
1325
32
. e7. https://doi.org/10.1053/j.gastro.2021.06.078.
19.
Coati
I
,
Fassan
M
,
Farinati
F
,
Graham
DY
,
Genta
RM
,
Rugge
M
.
Autoimmune gastritis: pathologist’s viewpoint
.
World J Gastroenterol
.
2015
;
21
(
42
):
12179
89
.
20.
Rugge
M
,
Savarino
E
,
Sbaraglia
M
,
Bricca
L
,
Malfertheiner
P
.
Gastritis: the clinico-pathological spectrum
.
Dig Liver Dis
.
2021 Oct 1
;
53
(
10
):
1237
46
.
21.
Moreno
A
,
Pares
X
.
Purification and characterization of a new alcohol dehydrogenase from human stomach
.
J Biol Chem
.
1991
;
266
(
2
):
1128
33
.
22.
Jokelainen
K
,
Roine
RP
,
Väänänen
H
,
Färkkilä
M
,
Salaspuro
M
.
In vitro acetaldehyde formation by human colonic bacteria
.
Gut
.
1994
;
35
(
9
):
1271
4
.
23.
Jokelainen
K
,
Siitonen
A
,
Jousimies-Somer
H
,
Nosova
T
,
Heine
R
,
Salaspuro
M
.
In vitro alcohol dehydrogenase-mediated acetaldehyde production by aerobic bacteria representing the normal colonic flora in man
.
Alcohol Clin Exp Res
.
1996
;
20
(
6
):
967
72
.
24.
Baan
R
,
Straif
K
,
Grosse
Y
,
Secretan
B
,
El Ghissassi
F
,
Bouvard
V
,
.
Carcinogenicity of alcoholic beverages
.
Lancet Oncol
.
2007
;
8
(
4
):
292
3
.
25.
Breslow
NE
,
Enstrom
JE
.
Geographic correlations between cancer mortality rates and alcohol-tobacco consumption in the United States
.
J Natl Cancer Inst
.
1974
;
53
(
3
):
631
9
.
26.
Sprince
H
,
Parker
CM
,
Smith
GG
,
Gonzales
LJ
.
Protective action of ascorbic acid and sulfur compounds against acetaldehyde toxicity: implications in alcoholism and smoking
.
Agents Actions
.
1975
;
5
(
2
):
164
73
.
27.
Sprince
H
.
Protective action of sulfur compounds against aldehyde toxicants of cigarette smoke
.
Eur J Respir Dis Suppl
.
1985
;
139
(
Suppl 139
):
102
12
.
28.
Salaspuro
V
,
Hietala
J
,
Kaihovaara
P
,
Pihlajarinne
L
,
Marvola
M
,
Salaspuro
M
.
Removal of acetaldehyde from saliva by a slow-release buccal tablet of L-cysteine
.
Int J Cancer
.
2002 Jan 20
;
97
(
3
):
361
4
.
29.
Salaspuro
VJ
,
Hietala
JM
,
Marvola
ML
,
Salaspuro
MP
.
Eliminating carcinogenic acetaldehyde by cysteine from saliva during smoking
.
Cancer Epidemiol Biomarkers Prev
.
2006 Jan
;
15
(
1
):
146
9
.
30.
Syrjänen
K
,
Salminen
J
,
Aresvuo
U
,
Hendolin
P
,
Paloheimo
L
,
Eklund
C
,
.
Elimination of cigarette smoke-derived acetaldehyde in saliva by slow-release L-cysteine lozenge is a potential new method to assist smoking cessation. A randomised, double-blind, placebo-controlled intervention
.
Anticancer Res
.
2016
;
36
(
5
):
2297
306
.
31.
Linderborg
K
,
Marvola
T
,
Marvola
M
,
Salaspuro
M
,
Färkkilä
M
,
Väkeväinen
S
.
Reducing carcinogenic acetaldehyde exposure in the achlorhydric stomach with cysteine
.
Alcohol Clin Exp Res
.
2011 Mar
;
35
(
3
):
516
22
.
32.
Maejima
R
,
Iijima
K
,
Kaihovaara
P
,
Hatta
W
,
Koike
T
,
Imatani
A
,
.
Effects of ALDH2 genotype, PPI treatment and L-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration
.
PLoS One
.
2015 Apr 1
;
10
(
4
):
e0120397
.
33.
Hellström
PM
,
Hendolin
P
,
Kaihovaara
P
,
Kronberg
L
,
Meierjohann
A
,
Millerhovf
A
,
.
Slow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis
.
Scand J Gastroenterol
.
2017 Feb 1
;
52
(
2
):
230
7
.
34.
Delgado
DA
,
Lambert
BS
,
Boutris
N
,
McCulloch
PC
,
Robbins
AB
,
Moreno
MR
,
.
Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults
.
J Am Acad Orthop Surg Glob Res Rev
.
2018 Mar
;
2
(
3
):
e088
.
35.
Comparato
G
,
Fanigliulo
L
,
Aragona
G
,
Cavestro
GM
,
Cavallaro
LG
,
Leandro
G
,
.
Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment
.
Dig Dis
.
2007
;
25
(
3
):
252
9
.
36.
Carabotti
M
,
Lahner
E
,
Esposito
G
,
Sacchi
MC
,
Severi
C
,
Annibale
B
.
Upper gastrointestinal symptoms in autoimmune gastritis a cross-sectional study
.
Medicine
.
2017
;
96
(
1
):
e5784
.
37.
Tosetti
C
,
Stanghellini
V
,
Tucci
A
,
Poli
L
,
Salvioli
B
,
Biasco
G
,
.
Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis
.
Dig Dis Sci
.
2000
;
45
(
2
):
252
7
.
38.
Rasmussen
S
,
Jensen
TH
,
Henriksen
SL
,
Haastrup
PF
,
Larsen
PV
,
Søndergaard
J
,
.
Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population
.
Scand J Gastroenterol
.
2015 Feb 1
;
50
(
2
):
162
9
.
39.
Soykan
I
,
Yakut
M
,
Keskin
O
,
Bektaş
M
.
Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis
.
Digestion
.
2012 Aug
;
86
(
1
):
20
6
.
40.
Kaji
M
,
Fujiwara
Y
,
Shiba
M
,
Kohata
Y
,
Yamagami
H
,
Tanigawa
T
,
.
Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life
.
J Gastroenterol Hepatol
.
2010
;
25
(
6
):
1151
6
.
41.
Lahner
E
,
Conti
L
,
Annibale
B
,
Corleto
VD
.
Current perspectives in atrophic gastritis
.
Curr Gastroenterol Rep
.
2020 Aug 1
;
22
(
8
):
38
.
42.
Dinis-Ribeiro
M
,
Yamaki
G
,
Miki
K
,
Costa-Pereira
A
,
Matsukawa
M
,
Kurihara
M
.
Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening
.
J Med Screen
.
2004
;
11
(
3
):
141
7
.
43.
Huang
YK
,
Yu
JC
,
Kang
WM
,
Ma
ZQ
,
Ye
X
,
Tian
SB
,
.
Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis
.
PLoS One
.
2015 Nov 10
;
10
(
11
):
e0142080
.
44.
Zagari
RM
,
Rabitti
S
,
Greenwood
DC
,
Eusebi
LH
,
Vestito
A
,
Bazzoli
F
.
Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis
.
Aliment Pharmacol Ther
.
2017 Oct 1
;
46
(
7
):
657
67
.
45.
Di Mario
F
,
Crafa
P
,
Grillo
S
,
Landi
S
,
Franceschi
M
,
Rodriguez-Castro
K
,
.
Recovery of gastric function in patients affected by chronic atrophic gastritis using l-cysteine (Acetium®): one year survey in comparison with a control group
.
Acta Biomed
.
2022
;
93
(
3
):
e2022184
.
46.
Choung
RS
,
Locke
GR
,
Schleck
CD
,
Zinsmeister
AR
,
Talley
NJ
.
Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities
.
Neurogastroenterol Motil
.
2012 Mar
;
24
(
3
):
229
34
, e106. https://doi.org/10.1111/j.1365-2982.2011.01845.x.
47.
Lee
SY
,
Lee
KJ
,
Kim
SJ
,
Cho
SW
.
Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study
.
Digestion
.
2009 Apr
;
79
(
3
):
196
201
.
48.
Di Mario
F
,
Stefani
N
,
ND
,
Rugge
M
,
Pilotto
A
,
Cavestro
GM
,
.
Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey
.
Dig Dis Sci
.
2005 Dec
;
50
(
12
):
2286
95
.
You do not currently have access to this content.